Organization (Other)
Kathmandu University School of Medical Sciences
ClinicalTrials.gov lists Kathmandu University School of Medical Sciences as lead sponsor of 26 trials. It has 23 active development programs and 1 approved asset.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 2 registered with a 2026 start date. The dashed outline is the pace from the 2 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 4.8 trial starts a year over the five years to September, under the 5 a year the method needs.
This page covers Kathmandu University School of Medical Sciences: 26 lead-sponsored trials and 0 legal-entity registrations.
Disease areas (44)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Diabetes Mellitus | 6 |
| Hypertension | 5 |
| Fractures, Bone | 3 |
| Pain | 3 |
| Back Pain | 2 |
Showing 5 of 44 disease areas.
Trials by start year as sponsor or collaborator (10)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2025 | 3 |
| 2024 | 9 |
| 2023 | 7 |
| 2022 | 3 |
| 2021 | 1 |
| 2019 | 4 |
| 2018 | 1 |
| 2017 | 3 |
| 2015 | 1 |
Prediction, not a registry value: median of 28 months from start to primary completion across 5 trials still running at the 2026-10-09 snapshot; registered median of 12 months across 14 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Active development programs (23)
Shown in this order: max phase, then active trials.
| Drug | Disease area | Max phase | Trials |
|---|---|---|---|
| Standard Course Antibiotics | Tibial Fractures | Not reported | 1 |
| Standard Course Antibiotics | Wound Infection | Not reported | 1 |
| Standard Course Antibiotics | Fractures, Bone | Not reported | 1 |
| Control (placebo) group | Hemorrhage | Not reported | 1 |
| Standard Course Antibiotics | Surgical Wound Infection | Not reported | 1 |
Showing 5 of 23 active programs.
Approved assets (1)
| Drug | Trials |
|---|---|
| Adrenaline | 1 |
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 2 of 4 hit target (n=4) | 1 of 4 on time (n=4) |
Journals published in (77)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| BMJ open | 8 |
| The Cochrane database of systematic reviews | 4 |
| BMC health services research | 3 |
| Child abuse & neglect | 3 |
| Lancet (London, England) | 3 |
Showing 5 of 77 journals.
Latest dated events (34)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-07-29 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-03-30 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-12-14 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-11-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-07-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 34 events.
Biomarker capability evidence (4)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| LBP | Trial sponsor | Named in trial inclusion criteria |
| TSPAN33 | Trial collaborator | Named in trial inclusion criteria |
| LBP | Trial sponsor | Mentioned in trial text |
| TSPAN33 | Trial collaborator | Mentioned in trial text |
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, organization relationships, clia clinical laboratory certificates, and biomarkers this organization publishes on.